BRAF V600 mutations are present in about 50% (43–66%) of primary or metastatic melanoma (Long et al. 2011; Colombino et al. 2012; Davies et al. 2002), thus the rate of 42% BRAF V600 mutated tumors in our study corresponds very well to the literature. Here, BRAF is linked to metastatic melanoma.